Xie, T.; Zhang, L.; Li, S.; Xu, B.; Zhang, X.; Wang, Y.; Shang, Z.; Xi, H.; Shi, H.; Ni, X.;
et al. Metabolic–Epigenetic Crosstalk in Takayasu Arteritis: The ANK2–MAVS–IL-8 Axis as a Novel Therapeutic Paradigm. Int. J. Mol. Sci. 2026, 27, 3249.
https://doi.org/10.3390/ijms27073249
AMA Style
Xie T, Zhang L, Li S, Xu B, Zhang X, Wang Y, Shang Z, Xi H, Shi H, Ni X,
et al. Metabolic–Epigenetic Crosstalk in Takayasu Arteritis: The ANK2–MAVS–IL-8 Axis as a Novel Therapeutic Paradigm. International Journal of Molecular Sciences. 2026; 27(7):3249.
https://doi.org/10.3390/ijms27073249
Chicago/Turabian Style
Xie, Tianjian, Leyu Zhang, Shurong Li, Benmo Xu, Xinyu Zhang, Yajun Wang, Zixiang Shang, Hongxuan Xi, Han Shi, Xin Ni,
and et al. 2026. "Metabolic–Epigenetic Crosstalk in Takayasu Arteritis: The ANK2–MAVS–IL-8 Axis as a Novel Therapeutic Paradigm" International Journal of Molecular Sciences 27, no. 7: 3249.
https://doi.org/10.3390/ijms27073249
APA Style
Xie, T., Zhang, L., Li, S., Xu, B., Zhang, X., Wang, Y., Shang, Z., Xi, H., Shi, H., Ni, X., Li, P., & Li, H.
(2026). Metabolic–Epigenetic Crosstalk in Takayasu Arteritis: The ANK2–MAVS–IL-8 Axis as a Novel Therapeutic Paradigm. International Journal of Molecular Sciences, 27(7), 3249.
https://doi.org/10.3390/ijms27073249